1048980-69-3

Upstream product

• 20894-13-7 (+/-)-5-methyl-5-nitro-4-phenylhexan-2-one 
• 20894-24-0 2,5,5-trimethyl-4-phenyl-3,4-dihydropyrrole 1-oxide 
• 119580-60-8 2,2,5,5-tetramethyl-3-phenylpyrrolidin-1-oxyl 

Relevant academic research and scientific papers

Drug Resistance Reversal In Neoplastic Disease

The present invention is directed to compounds, compositions, and methods for halting or reversing the effects of chemoresistance in neoplastic diseases. In particular the use of hydroxylamines is described.

HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE

The present disclosure provides compounds that include hydroxylamines of formula (I) or (II), pharmaceutical compositions, and methods for their use. The methods utilize hydroxylamine compounds and/or their pharmaceutical compositions for the treatment of angiogenesis, hepatitis, complement-mediated pathologies, drusen-mediated pathologies, macular degeneration and certain other ophthalmic conditions, inflammation, arthritis, and related diseases and for the inhibition of complement activation.